Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030. (October 2022)
- Record Type:
- Journal Article
- Title:
- Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030. (October 2022)
- Main Title:
- Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030
- Authors:
- Zare Jeddi, Maryam
Hopf, Nancy B.
Louro, Henriqueta
Viegas, Susana
Galea, Karen S.
Pasanen-Kase, Robert
Santonen, Tiina
Mustieles, Vicente
Fernandez, Mariana F.
Verhagen, Hans
Bopp, Stephanie K.
Antignac, Jean Philippe
David, Arthur
Mol, Hans
Barouki, Robert
Audouze, Karine
Duca, Radu-Corneliu
Fantke, Peter
Scheepers, Paul
Ghosh, Manosij
Van Nieuwenhuyse, An
Lobo Vicente, Joana
Trier, Xenia
Rambaud, Loïc
Fillol, Clémence
Denys, Sebastien
Conrad, André
Kolossa-Gehring, Marike
Paini, Alicia
Arnot, Jon
Schulze, Florian
Jones, Kate
Sepai, Ovnair
Ali, Imran
Brennan, Lorraine
Benfenati, Emilio
Cubadda, Francesco
Mantovani, Alberto
Bartonova, Alena
Connolly, Alison
Slobodnik, Jaroslav
Bruinen de Bruin, Yuri
van Klaveren, Jacob
Palmen, Nicole
Dirven, Hubert
Husøy, Trine
Thomsen, Cathrine
Virgolino, Ana
Röösli, Martin
Gant, Tim
von Goetz, Natalie
Bessems, Jos
… (more) - Abstract:
- Abstract: Human biomonitoring (HBM) is a crucial approach for exposure assessment, as emphasised in the European Commission's Chemicals Strategy for Sustainability (CSS). HBM can help to improve chemical policies in five major key areas: (1) assessing internal and aggregate exposure in different target populations; 2) assessing exposure to chemicals across life stages; (3) assessing combined exposure to multiple chemicals (mixtures); (4) bridging regulatory silos on aggregate exposure; and (5) enhancing the effectiveness of risk management measures. In this strategy paper we propose a vision and a strategy for the use of HBM in chemical regulations and public health policy in Europe and beyond. We outline six strategic objectives and a roadmap to further strengthen HBM approaches and increase their implementation in the regulatory risk assessment of chemicals to enhance our understanding of exposure and health impacts, enabling timely and targeted policy interventions and risk management. These strategic objectives are: 1) further development of sampling strategies and sample preparation; 2) further development of chemical-analytical HBM methods; 3) improving harmonisation throughout the HBM research life cycle; 4) further development of quality control / quality assurance throughout the HBM research life cycle; 5) obtain sustained funding and reinforcement by legislation; and 6) extend target-specific communication with scientists, policymakers, citizens and otherAbstract: Human biomonitoring (HBM) is a crucial approach for exposure assessment, as emphasised in the European Commission's Chemicals Strategy for Sustainability (CSS). HBM can help to improve chemical policies in five major key areas: (1) assessing internal and aggregate exposure in different target populations; 2) assessing exposure to chemicals across life stages; (3) assessing combined exposure to multiple chemicals (mixtures); (4) bridging regulatory silos on aggregate exposure; and (5) enhancing the effectiveness of risk management measures. In this strategy paper we propose a vision and a strategy for the use of HBM in chemical regulations and public health policy in Europe and beyond. We outline six strategic objectives and a roadmap to further strengthen HBM approaches and increase their implementation in the regulatory risk assessment of chemicals to enhance our understanding of exposure and health impacts, enabling timely and targeted policy interventions and risk management. These strategic objectives are: 1) further development of sampling strategies and sample preparation; 2) further development of chemical-analytical HBM methods; 3) improving harmonisation throughout the HBM research life cycle; 4) further development of quality control / quality assurance throughout the HBM research life cycle; 5) obtain sustained funding and reinforcement by legislation; and 6) extend target-specific communication with scientists, policymakers, citizens and other stakeholders. HBM approaches are essential in risk assessment to address scientific, regulatory and societal challenges. HBM requires full and strong support from the scientific and regulatory domain to reach its full potential in public and occupational health assessment and in regulatory decision-making. … (more)
- Is Part Of:
- Environment international. Volume 168(2022)
- Journal:
- Environment international
- Issue:
- Volume 168(2022)
- Issue Display:
- Volume 168, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 168
- Issue:
- 2022
- Issue Sort Value:
- 2022-0168-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-10
- Subjects:
- Human biomonitoring -- Chemicals mixtures -- Data governance -- Zero Pollution Ambition -- One substance-one assessment -- Circular economy
Environmental protection -- Periodicals
Environmental health -- Periodicals
Environmental monitoring -- Periodicals
Environmental Monitoring -- Periodicals
Environnement -- Protection -- Périodiques
Hygiène du milieu -- Périodiques
Environnement -- Surveillance -- Périodiques
Environmental health
Environmental monitoring
Environmental protection
Periodicals
333.705 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01604120 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.envint.2022.107476 ↗
- Languages:
- English
- ISSNs:
- 0160-4120
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3791.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23409.xml